US 9000191
Serotonin reuptake inhibitors
granted A61PA61P1/00A61P1/04
Quick answer
US patent 9000191 (Serotonin reuptake inhibitors) held by Theravance Biopharma R&D IP, LLC expires Mon Apr 02 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Theravance Biopharma R&D IP, LLC
- Grant date
- Tue Apr 07 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 02 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 2
- CPC classes
- A61P, A61P1/00, A61P1/04, A61P11/00, A61P19/02